Researchers are reportedly working on a vaccine to combat humans' response to poison ivy. According to Scientific American, scientists at the University of Mississippi and Hapten Sciences are ...

Researchers are reportedly working on a vaccine to combat humans’ response to poison ivy. According to Scientific American, scientists at the University of Mississippi and… ...

MEMPHIS, Tenn., Nov. 19, 2015 /PRNewswire/ -- Hapten Sciences, Inc., a privately held biotechnology company, announced today that it has filed an Investigational New Drug (IND) application and is ...

Epidermal application of reactive haptens such as urushiol, the reactive agent in poison ivy, and subsequent challenge results in the development of a T cell mediated inflammatory response termed ...

Hapten received a one-time, upfront cash payment of $100,000 and 200,000 shares of RXi common stock under the terms of the agreement.

Background: To observe the effect of adjuvant on the clinical efficacy and survival period of patients with liver cancer treated by UMIPIC (Ultra-minimum Incision personalized intratumoral ...

Since the hapten-antibody interactions are different in the three antibodies, as shown by the difference spectra, the structures of the combining sites are presumably also different. We have ...